An international study of improving treatment for the most severely ill with schizophrenia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN41543404

Enrollment

100

Registered

2003-09-12

Start date

2001-03-20

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Schizophrenia Mental and Behavioural Disorders Schizophrenia

Interventions

A double-blind, randomised controlled trial of risperidone compared to placebo augmentation will be carried out with 100 subjects. All subjects will continue on clozapine therapy. Symptomatic, functio

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 100 Subjects (PROJ 16/10/2000)

Exclusion criteria

Exclusion criteria: Does not match inclusion criteria

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026